Study reveals systemic barriers preventing Black Canadians from donating critical blood

Canada has a blood shortage problem, but it's not the kind you hear about in public health announcements. The shortage is specific: the country lacks sufficient donors from Black communities, and this gap has direct consequences for patients with sickle cell disease who need carefully matched transfusions to survive. A new study published in the Canadian Medical Association Journal reveals why Black Canadians who want to give blood often cannot—and the reasons run deeper than simple logistics.

Researchers at the University of Ottawa's Interdisciplinary Centre for Black Health interviewed 42 Black adults across Canada to understand what keeps them from donating. Most were well-educated, holding bachelor's degrees or higher. What emerged from their accounts was not a story of indifference but of systematic exclusion and accumulated mistrust. The barriers, as the researchers describe them, are rooted in three overlapping problems: the policies themselves, the lived experience of racism within health institutions, and the weight of Canadian history.

Start with policy. Canada's blood donation rules are stricter than those of comparable wealthy nations. A person who has had malaria, for instance, is permanently barred from donating in Canada. The United States removed this restriction years ago. France did too. Many other G7 countries have reformed their policies to allow donations from people whose malaria risk has passed. Canada has not. For people with family ties to regions where malaria is endemic—which includes much of Africa—this rule functions as a categorical exclusion. It is not the only one. The cumulative effect is that Black Canadians encounter more barriers to entry than donors from other backgrounds.

But policy alone does not explain the full picture. Participants in the study described negative encounters with healthcare workers and institutions. Some feared they would not be treated with respect during the donation process. Others had experienced dismissal or disrespect in medical settings and carried that experience into their thinking about blood banks. These were not abstract fears. They were rooted in real interactions and in the broader context of how Black people have been treated within Canadian healthcare. The researchers note that historical anti-Black racism has left many Black Canadians feeling devalued by institutions that are supposed to serve them. When you add that historical weight to a present-day interaction, trust becomes fragile.

The human cost is concrete. Sickle cell disease affects people of African, Middle Eastern, and South Asian descent disproportionately. Patients with sickle cell require red blood cell transfusions matched to their blood type and other characteristics. When the donor pool is too small, patients wait longer for treatment or receive less optimal matches. The shortage of Black donors means Black patients with sickle cell disease face inadequate access to the blood they need.

Dr. Jude Mary Cénat, a psychology professor at the University of Ottawa and lead author of the study, and his colleagues are clear about what needs to happen next. Canadian Blood Services, which manages donations in most of the country, and Héma-Québec, which handles Quebec, need to do more than tinker at the margins. They need to reform restrictive policies that have no medical justification in the Canadian context. They need to launch engagement campaigns that acknowledge the history of mistrust rather than ignore it. They need to listen to Black communities about what would make donation feel safe and respectful. The researchers emphasize that this is not about charity or goodwill. It is about removing barriers that expose Black Canadians to racism and harm Black patients who depend on matched blood. The two organizations managing Canada's blood supply now have a clear map of what is broken and what needs to change.